Ceradyne, Inc. (CRDN) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts CRDN Hot Sheet
Join SI Premium – FREE
Ceradyne, Inc. (NASDAQ: CRDN) reported Q3 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $148 million versus the consensus estimate of $141.92 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
